NIH Scientists Develop Novel Surgical Technique for Multiple Retinal Grafts in AMD Treatment

Breakthrough in Retinal Graft Surgery

Scientists at the National Institutes of Health (NIH) have developed a groundbreaking surgical technique that allows for the implantation of multiple tissue grafts in the eye's retina. This innovation could potentially revolutionize treatment options for dry age-related macular degeneration (AMD), a leading cause of vision loss among older adults. The findings, published in JCI Insight, mark a significant advancement in the field of ophthalmology 1

1

2

3

Source: Neuroscience News

The Challenge of AMD and Current Limitations

AMD is characterized by the degeneration of light-sensitive retinal tissue at the back of the eye. While scientists have been exploring therapies using lab-grown tissue grafts derived from patient stem cells, current surgical techniques have been limited to placing only one graft in the retina. This restriction has hampered both the treatable area in patients and the ability to conduct side-by-side comparisons in animal models 1

1

2

Innovative Surgical Technique

The NIH team designed a novel surgical clamp that maintains eye pressure during the insertion of two tissue patches in immediate succession, minimizing damage to surrounding tissue. This technique allows for the placement of multiple grafts, expanding the potential treatment area and enabling crucial comparative studies 1

1

2

3

Animal Model Study and Results

In their animal model experiments, the scientists compared two different grafts placed sequentially in the same experimentally induced AMD-like lesion:

1. A graft consisting of retinal pigment epithelial (RPE) cells grown on a biodegradable scaffold
2. A control graft composed of just the biodegradable scaffold

Post-surgery analysis using artificial intelligence revealed that the RPE grafts significantly promoted the survival of photoreceptors, while photoreceptors near scaffold-only grafts died at a much higher rate. Importantly, the study confirmed for the first time that the RPE graft also regenerated the choriocapillaris, a network of blood vessels crucial for supplying oxygen and nutrients to the retina 1

1

2

3

Source: News-Medical

Related Stories

Breakthrough Electronic Eye Implant Restores Reading Vision in Blind Patients

NIH Scientists Revolutionize Eye Imaging with AI-Enhanced Ophthalmoscopy

New AI technology speeds eye disease diagnosis and predicts heart attack, stroke risks from retinal scans

AI-Powered Retinal Mapping Breakthrough: A New Frontier in Disease Detection

Implications for AMD Treatment

These findings expand on the capabilities demonstrated in an ongoing NIH-led first-in-human clinical trial of patient-derived RPE grafts for dry AMD. The new technique allows for treating larger and noncontiguous retinal degeneration areas in a single surgery, potentially improving outcomes for patients with advanced AMD 1

1

3

Future Prospects

The success of this technique in animal models paves the way for further research and potential clinical applications. By enabling side-by-side comparisons and larger treatment areas, this innovation could accelerate the development of more effective therapies for AMD and other retinal degenerative diseases 2

2

3

As the global population ages, the incidence of AMD is expected to rise, making advancements in treatment options increasingly crucial. This breakthrough by NIH scientists represents a significant step forward in addressing this growing health concern and offers hope for preserving and restoring vision in affected individuals.